23 October 2018 - Drugstore giant CVS’s puzzling fluctuation in pricing for meds have been hitting mom and pop pharmacists hard — and they’ve caught the notice of New York regulators.

Tom D’Angelo, who owns a pharmacy on Long Island, claims he has lost “hundreds of thousands of dollars” over the past couple of years because of tough tactics from Caremark, CVS’s pharmacy-benefits manager, or PBM.

D’Angelo claims Caremark, which is a prescription middleman that dictates its reimbursement pricing, has subjected him to wild, unpredictable fluctuations in reimbursement rates for prescription drugs.

Read New York Post article